about
Adrenoleukodystrophy-related protein can compensate functionally for adrenoleukodystrophy protein deficiency (X-ALD): implications for therapyPeroxisomal localization of the proopiomelanocortin-derived peptides beta-lipotropin and beta-endorphinDistribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophyPeroxisomes in brain development and functionThe similarity between N-terminal targeting signals for protein import into different organelles and its evolutionary relevanceThe genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosisRevised nomenclature for the mammalian long-chain acyl-CoA synthetase gene familyMouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cellsVery long-chain acyl-CoA synthetase 3: overexpression and growth dependence in lung cancerAcyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolismProteomics characterization of mouse kidney peroxisomes by tandem mass spectrometry and protein correlation profilingHomeostasis of phospholipids - The level of phosphatidylethanolamine tightly adapts to changes in ethanolamine plasmalogens.Rat adrenoleukodystrophy-related (ALDR) gene: full-length cDNA sequence and new insight in expression.The difference in recognition of terminal tripeptides as peroxisomal targeting signal 1 between yeast and human is due to different affinities of their receptor Pex5p to the cognate signal and to residues adjacent to it.Peroxisomal alterations in Alzheimer's diseaseCD1 gene polymorphisms and phenotypic variability in X-linked adrenoleukodystrophy.Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient micePathophysiology of X-linked adrenoleukodystrophy.cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDRP), a peroxisomal ABC transporter.Liver X receptor alpha interferes with SREBP1c-mediated Abcd2 expression. Novel cross-talk in gene regulation.A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein genes with a distinct expression pattern.X-linked adrenoleukodystrophy: clinical, biochemical and pathogenetic aspects.Mechanistic insights into PTS2-mediated peroxisomal protein import: the co-receptor PEX5L drastically increases the interaction strength between the cargo protein and the receptor PEX7Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy.Structural requirements for interaction of peroxisomal targeting signal 2 and its receptor PEX7.Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.Involvement of human peroxisomes in biosynthesis and signaling of steroid and peptide hormones.X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.Drebrin depletion alters neurotransmitter receptor levels in protein complexes, dendritic spine morphogenesis and memory-related synaptic plasticity in the mouse hippocampus.Proteome profiling in the rat Harderian gland.Ether lipid deficiency does not cause neutropenia or leukopenia in mice and men.Eight novel ABCD1 gene mutations and three polymorphisms in patients with X-linked adrenoleukodystrophy: The first polymorphism causing an amino acid exchange.Investigations of micro-organic brain damage (MOBD) in heterozygotes of metachromatic leukodystrophy.Thyroid hormone induction of the adrenoleukodystrophy-related gene (ABCD2).Evaluation of the therapeutic potential of PPARalpha agonists for X-linked adrenoleukodystrophy.The four murine peroxisomal ABC-transporter genes differ in constitutive, inducible and developmental expression.X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism.Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction.
P50
Q22009167-17680E89-F5F8-42D6-BE77-13BE53BD286FQ24298250-E9C9E10E-FA97-4910-98FA-13A8B9EF8DDCQ24338719-2944273E-2A48-477F-8201-F55ECA4D26BEQ26774697-C2AD6912-D0CB-4C04-ABDF-B28C780A2C13Q26781543-FD1AE623-5CD9-4528-A4EA-96701196F3DAQ26829999-C5BA8A76-9740-4E69-8E10-77462CB070D7Q28275533-EAF6052B-0398-47CC-9AB5-9A744BF10741Q28504573-14315211-9ACA-487D-9F24-1EDF29BB62B0Q28534769-4FECEC4E-B110-4DA1-8A1B-9055033B2B4DQ28586519-F5B11F8D-1723-426A-B203-12C99BA621E5Q28591793-E1B420A4-AC06-4212-A3A3-C8657389903EQ30417407-3F1F2ED6-81D0-4EA5-AA1E-6FB924B35AD3Q30988982-61C29C4A-8D55-496A-9E06-99EE07FE3DEFQ31962320-F9906252-2B06-4EB6-AA3F-BFA6441DCC03Q33905478-B4AEA7EB-8DDA-47A8-BE91-C04E86FF83C1Q34130740-5D2F25A8-0AE5-4047-A53E-1B3E027F2506Q34249977-906CC2AB-FE56-4AAF-862D-4A303877C2CBQ34257373-23E2EB1D-0A80-44C3-A9A3-A1D7AF548903Q34390414-7E378AF8-7587-4730-9243-78764DC33C0CQ34444000-ED2C9D83-B7C7-4B12-86F0-7D5B54BADA87Q34462811-20FCD1CE-EA49-4082-BCEE-20E4E548E116Q34473393-DDBFFAC1-9805-4B69-8951-9ECB4B3F9737Q34562917-E2E3AA03-92E4-4A25-9B13-A7D1FE543162Q35103958-9BDCD662-43B4-4F95-91F2-32E15EF9BA44Q35216369-476A2C55-4979-4802-87F0-CBF2A2C70660Q35639857-7CE65500-9E64-4954-9726-7228EDF20248Q36967430-D70AB070-C54E-4BBA-95CA-A766E14E640EQ38000843-0BCE082E-91BE-4D6C-9CBB-946D93533E58Q38118913-6F185D30-E45B-49FB-9CDE-FA354BF97A33Q38806290-AA74BC01-73AF-4C06-965B-317B73B708EAQ39018885-BBD2CFEC-406E-45FB-813E-BD28E6308912Q40309475-5A432894-4437-4DC9-8E4B-1946C16D3E67Q42751793-9B3A28EE-C88B-42F4-BE5E-BBDAFBABA681Q43663109-5C505C0C-CA17-4AB0-BFA9-F6267273BE1EQ44063117-D0FB4CDB-B696-4994-893A-E7CE0E790AE9Q44449920-53F250CA-FF39-4688-A492-CDF663BB108EQ44679119-AF600714-5B06-4324-A7D6-C190885212BAQ45862493-14AB65B8-C5AD-4CA0-93C3-F7328C8CE5E4Q46742739-2B17B25A-B826-44EE-BD2E-4FE0A7BD0B0EQ47140716-98D6E6AE-E023-4A23-B711-FB172F93D8B1
P50
description
hulumtues
@sq
investigador mèdic
@ca
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Johannes Berger
@ast
Johannes Berger
@ca
Johannes Berger
@en
Johannes Berger
@es
Johannes Berger
@nl
Johannes Berger
@sl
type
label
Johannes Berger
@ast
Johannes Berger
@ca
Johannes Berger
@en
Johannes Berger
@es
Johannes Berger
@nl
Johannes Berger
@sl
prefLabel
Johannes Berger
@ast
Johannes Berger
@ca
Johannes Berger
@en
Johannes Berger
@es
Johannes Berger
@nl
Johannes Berger
@sl
P1053
A-9122-2014
P106
P1153
7403413425
P21
P31
P3829
P496
0000-0003-0182-2658